Third Harmonic Bio, Inc. 4 SEC Filings

Filed On	Filing
14 Aug 2025	Form 4: Holles Natalie C., Director Disposed of 1,218,836 shares (Other Transaction) · Disposed of 998,854 Stock Option (Other Transaction) · Disposed of 50,000 Restricted Stock Unit (Other Transaction)
14 Aug 2025	Form 4: Gladstone Michael, Director Disposed of 43,584 Stock Option (Other Transaction)
14 Aug 2025	Form 4: Murphy Christopher M., Chief Financial & Bus. Officer Disposed of 47,500 Restricted Stock Unit (Other Transaction)
14 Aug 2025	Form 4: Iwicki Mark T, Director Disposed of 128,631 shares (Other Transaction) · Disposed of 83,296 Stock Option (Other Transaction)
14 Aug 2025	Form 4: Seidel Hans Martin, Director Disposed of 85,753 shares (Other Transaction) · Disposed of 53,090 Stock Option (Other Transaction)
14 Aug 2025	Form 4: Soloway Thomas P, Director Disposed of 120,166 Stock Option (Other Transaction)
14 Aug 2025	Form 4: Bonita David P, Director Disposed of 5,779,071 shares (Other Transaction) · Disposed of 43,584 Stock Option (Other Transaction)
05 Mar 2025	Form 4: Murphy Christopher M., Chief Financial & Bus. Officer Granted 30,000 Restricted Stock Unit
17 Jan 2025	Form 4: Murphy Christopher M., Chief Financial & Bus. Officer Granted 140,000 Employee Stock Option (right to buy) · Granted 17,500 Restricted Stock Unit
17 Jan 2025	Form 4: Dittman Jennifer, Chief Operating Officer Granted 92,000 Employee Stock Option (right to buy) · Granted 11,500 Restricted Stock Unit
17 Jan 2025	Form 4: Conner Edward R., Chief Medical Officer Granted 132,000 Employee Stock Option (right to buy) · Granted 16,500 Restricted Stock Unit
17 Jan 2025	Form 4: Person Julie, CHIEF ADMINISTRATIVE OFFICER Granted 100,000 Employee Stock Option (right to buy) · Granted 12,500 Restricted Stock Unit
17 Jan 2025	Form 4: Dinsmore Christopher, Chief Scientific Officer Granted 116,000 Employee Stock Option (right to buy) · Granted 14,500 Restricted Stock Unit
17 Jan 2025	Form 4: Dean Dennis, Chief Nonclinical Dev. Officer Granted 92,000 Employee Stock Option (right to buy) · Granted 11,500 Restricted Stock Unit
17 Jan 2025	Form 4: Holles Natalie C., Director Granted 400,000 Employee Stock Option (right to buy) · Granted 50,000 Restricted Stock Unit
12 Nov 2024	Form 4: Conner Edward R., Chief Medical Officer Received 2,117 shares by exercise or conversion ($8.89K) · Sold 2,117 shares ($31.8K)
05 Nov 2024	Form 4: Atlas Venture Fund XI, L.p., 10% owner Disposed of 515,688 shares (Other Transaction)
31 Oct 2024	Form 4: Bvf Partners L P/IL, See Explanation of Responses and 9 others Sold 1,000,000 shares ($14.3M)
30 Oct 2024	Form 4: Conner Edward R., Chief Medical Officer Received 2,673 shares by exercise or conversion ($11.2K) · Sold 2,673 shares ($40.1K)
20 Sep 2024	Form 4: Conner Edward R., Chief Medical Officer Received 4,790 shares by exercise or conversion ($20.1K) · Sold 4,790 shares ($71.9K)

Comments